BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 8799686)

  • 21. Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months.
    Prescrire Int; 2013 May; 22(138):129-33. PubMed ID: 23819181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of venous thromboembolism: optimization by clinical trials.
    Turpie AG
    Haemostasis; 1996 Oct; 26 Suppl 4():220-6. PubMed ID: 8979127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low molecular weight heparin, heparin, and warfarin.
    Raskob GE
    Curr Opin Hematol; 1995 Sep; 2(5):372-9. PubMed ID: 9372022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparin and low-molecular-weight heparin therapy for venous thromboembolism: will unfractionated heparin survive?
    Hull RD; Pineo GF
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():11-23. PubMed ID: 15085462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study.
    Meyer G; Marjanovic Z; Valcke J; Lorcerie B; Gruel Y; Solal-Celigny P; Le Maignan C; Extra JM; Cottu P; Farge D
    Arch Intern Med; 2002 Aug 12-26; 162(15):1729-35. PubMed ID: 12153376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin and low-molecular-weight heparin in the treatment of venous thromboembolism.
    Pineo GF; Hull RD
    Baillieres Clin Haematol; 1998 Sep; 11(3):621-37. PubMed ID: 10331096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended outpatient therapy with low molecular weight heparin for the treatment of recurrent venous thromboembolism despite warfarin therapy.
    Luk C; Wells PS; Anderson D; Kovacs MJ
    Am J Med; 2001 Sep; 111(4):270-3. PubMed ID: 11566456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of thrombosis with warfarin, aspirin, and mechanical methods.
    Merli GJ
    Clin Cornerstone; 2005; 7(4):49-56. PubMed ID: 16758652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombotic drugs: part I.
    Gallus AS; Hirsh J
    Drugs; 1976; 12(1):41-68. PubMed ID: 789043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticoagulation for venous thromboembolism. What are the current options?
    Yacovella T; Alter M
    Postgrad Med; 2000 Sep; 108(4):43-6, 51-4. PubMed ID: 11021258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism.
    ; Büller HR; Gent M; Gallus AS; Ginsberg J; Prins MH; Baildon R
    N Engl J Med; 1997 Sep; 337(10):657-62. PubMed ID: 9280815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of antithrombotic drugs in older people.
    Tufano A; Cerbone AM; Di Minno G
    Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preventing venous thromboembolism].
    Encke A; Haas S
    Chirurg; 2007 Feb; 78(2):110, 112-8. PubMed ID: 17265054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapy of acute thromboembolism with heparin and warfarin.
    Carter BL
    Clin Pharm; 1991 Jul; 10(7):503-18. PubMed ID: 1860301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thromboembolism.
    Fitzmaurice D; Hobbs FD; McManus R
    Clin Evid; 2004 Dec; (12):285-308. PubMed ID: 15865639
    [No Abstract]   [Full Text] [Related]  

  • 36. Thromboembolism.
    Fitzmaurice D; Hobbs FR; McManus R
    Clin Evid; 2003 Dec; (10):273-88. PubMed ID: 15555092
    [No Abstract]   [Full Text] [Related]  

  • 37. Venous thromboembolism prophylaxis and treatment in patients with acute stroke and traumatic brain injury.
    Vergouwen MD; Roos YB; Kamphuisen PW
    Curr Opin Crit Care; 2008 Apr; 14(2):149-55. PubMed ID: 18388676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of recurrent venous thromboembolism in cancer patients.
    Romualdi E; Ageno W
    Thromb Res; 2016 Apr; 140 Suppl 1():S128-31. PubMed ID: 27067966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contemporary use of and future roles for heparin in antithrombotic therapy.
    Gibaldi M; Wittkowsky AK
    J Clin Pharmacol; 1995 Nov; 35(11):1031-45. PubMed ID: 8626875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of venous thrombosis.
    Hirsh J
    Haemostasis; 1996 Oct; 26 Suppl 4():189-98. PubMed ID: 8979124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.